HAN KWANG YANG
Han-Kwang YANG, MD, PhD, FACS, Hon ASA, Hon ESA & Hon JSES
Professor, Department of Surgery, at Seoul National Univ. Hospital & Seoul National Univ. College of Medicine.
Dr. Yang is involved in several large scale RCT’s for gastric cancer treatment. He was Korean PI of REGATTA study (Phase III study for the role of gastrectomy in stage IV gastric cancer with a single incurable factor; a collaboratory study between JCOG and KGCA). He is investigators of CLASSIC trial, KLASS trials as well as the Korean PI of a phase II study for the role of neoadjuvant imatinib treatment in large gastric GIST (a collaborator study between Japan and Korea). He is the founding chairman of KLASS (Korean Laparoscopic Gastrointestinal Surgery Study Group) and contributed in MIS in gastric cancer especially Function preserving gastrectomy (pylorus preserving gastrectomy). His translational research interests are gastric carcinogenesis, DDS, familial gastric cancer, biomarkers and developing PDX model for gastric cancer. He is Secretary General of International Gastric Cancer Association, Honorary fellow of American Surgical Association, Honorary member of European Surgical Association, Honorary International Fellow of Japanese Society of Endoscopic Surgery and a member of Korea Korean Academy of Science and Technology (KAST). He served as editor or editorial member of ‘Gastric Cancer’ (the official journal of IGCA), Asian Journal of Endoscopic Surgery, Annals of Surgery etc. Dr. Yang gave over 380 invited lectures to international meetings and oversea institutes with occasional live demonstration of gastrectomy (open, laparoscopic or robotic).
Professor, Department of Surgery, at Seoul National Univ. Hospital & Seoul National Univ. College of Medicine.
Dr. Yang is involved in several large scale RCT’s for gastric cancer treatment. He was Korean PI of REGATTA study (Phase III study for the role of gastrectomy in stage IV gastric cancer with a single incurable factor; a collaboratory study between JCOG and KGCA). He is investigators of CLASSIC trial, KLASS trials as well as the Korean PI of a phase II study for the role of neoadjuvant imatinib treatment in large gastric GIST (a collaborator study between Japan and Korea). He is the founding chairman of KLASS (Korean Laparoscopic Gastrointestinal Surgery Study Group) and contributed in MIS in gastric cancer especially Function preserving gastrectomy (pylorus preserving gastrectomy). His translational research interests are gastric carcinogenesis, DDS, familial gastric cancer, biomarkers and developing PDX model for gastric cancer. He is Secretary General of International Gastric Cancer Association, Honorary fellow of American Surgical Association, Honorary member of European Surgical Association, Honorary International Fellow of Japanese Society of Endoscopic Surgery and a member of Korea Korean Academy of Science and Technology (KAST). He served as editor or editorial member of ‘Gastric Cancer’ (the official journal of IGCA), Asian Journal of Endoscopic Surgery, Annals of Surgery etc. Dr. Yang gave over 380 invited lectures to international meetings and oversea institutes with occasional live demonstration of gastrectomy (open, laparoscopic or robotic).
Confira a agenda de atividades
27 DE JUNHO | QUINTA-FEIRA
• Grande Auditório
• CIRURGIA DO ESTÔMAGO
10:00-11:00
CONFERÊNCIAS: CIRURGIA DO ESTÔMAGO
Recent evolution of surgical science in gastric cancer treatment: Beyond Minimally invasive surgery
Q&A
Landmark Clinical Trials
Q&A
Moderador: Ulysses Ribeiro Júnior (SP)
Recent evolution of surgical science in gastric cancer treatment: Beyond Minimally invasive surgery
Palestrante: Han Kwang Yang (Coréia do Sul)
Q&A
Landmark Clinical Trials
Palestrante: Henk Hartgrink (Holanda)
Q&A
PATROCÍNIO PRATA
PATROCÍNIO BRONZE
PATROCÍNIO
APOIO INSTITUCIONAL
Gerenciamento
